Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity

NCT01180231 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Moxonidine (Physiotens)
OTHER: Dietary intervention

Sponsor

Baker Heart and Diabetes Institute